During the past decade, Buffalo Rheumatology and Medicine PLLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Buffalo Rheumatology and Medicine PLLC" #1 sponsor was "Pfizer" with 4 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Ampel BioSolutions, LLC" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buffalo Rheumatology and Medicine PLLC" #1 collaborator was "IND 2 Results LLC" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Buffalo Rheumatology and Medicine PLLC" are "Rheumatoid Arthritis" (6 trials), "Gout" (2 trials), "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Buffalo Rheumatology and Medicine PLLC" in a lesser frequency.

Most popular intervention types in "Buffalo Rheumatology and Medicine PLLC" are "Drug" (13 trials), "Biological" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pegloticase" (2 trials), "acetaminophen" (2 trials), "methotrexate" (2 trials) and "methylprednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Buffalo Rheumatology and Medicine PLLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Buffalo Rheumatology and Medicine PLLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Buffalo Rheumatology and Medicine PLLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Buffalo Rheumatology and Medicine PLLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".